Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

Xiao-Dong Jiang; Yun Qiao; Peng Dai; Jin Wu; Da-An Song; Shi-Qiu Li; Yue-Wei Fan

首页> 外文期刊>Clinical and Translational Oncology >Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

【24h】

Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

机译：每周重组人内皮抑素作为缺氧肿瘤细胞放射增敏剂联合放疗治疗NSCLC的初步临床研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To investigate the clinical effects and adverse effects of weekly recombinant human endostatin (RHES) as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of non-small-cell lung cancer (NSCLC).

机译：目的探讨每周重组人内皮抑素（RHES）作为低氧肿瘤细胞放射增敏剂联合放疗治疗非小细胞肺癌（NSCLC）的临床疗效和不良反应。

著录项

来源
《Clinical and Translational Oncology》 |2012年第6期|p.465-470|共6页
作者
Xiao-Dong Jiang; Yun Qiao; Peng Dai; Jin Wu; Da-An Song; Shi-Qiu Li; Yue-Wei Fan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC [J] . JiangX.-D., QiaoY., DaiP., Clinical & translational oncology : . 2012,第6期

机译：每周重组人内皮抑素作为缺氧肿瘤细胞放射增敏剂联合放疗治疗NSCLC的初步临床研究
2. Continuous Intravenous Pumping of Recombinant Human Endostatin Combined With Concurrent Chemoradiation Therapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: Preliminary Data of a Prospective Multicenter Phase 1/2 Clinical Trial (NCT01733589) [J] . Hui Z., Ma H., Wu R., International Journal of Radiation Oncology, Biology, Physics . 2014,第5Suppla期

机译：不可切除的III期非小细胞肺癌患者持续静脉注射重组人内皮抑素并同时进行化学放疗：一项预期的多中心1/2期临床试验的初步数据（NCT01733589）
3. Recombinant human endostatin combined with radiotherapy in the treatment of brain metastases of non-small cell lung cancer. [J] . X Jiang, M Ding, Y Qiao, Clinical & translational oncology : . 2014,第7期

机译：重组人内皮抑素联合放疗治疗非小细胞肺癌脑转移。
4. TricOs~(TM) and Fibrin Sealant Combined for Bone Defect Filling: From Pre-Clinical Tests to Prospective Clinical Study. Preliminary human data [C] . M. Durand, D. Chauveaux, M. Moinard, Bioceramics . 2008

机译：TricOsTM和纤维蛋白封闭剂联合用于骨缺损的填充：从临床前测试到预期的临床研究。初步人类数据
5. Studies of DNA Double Strand Break Repair in Hypoxic S-phase Tumour Cells. [D] . Zak, Jan. 2016

机译：缺氧S期肿瘤细胞中DNA双链断裂修复的研究。
6. Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus [O] . Z Zhong, X Gu, Z Zhang, 2012

机译：重组人内皮抑素联合确定性放化疗作为主要治疗不可切除但无系统性食管鳞癌的患者
7. Recombinant human endostatin combined with definitive chemoradiotherapy as primary treatment for patients with unresectable but without systemic metastatic squamous cell carcinoma of the oesophagus [O] . Z Zhong, X Gu, Z Zhang, 2012

机译：重组人内皮素与明确的化学疗法相结合作为患者的初级治疗，患者患者，但没有食道的全身转移鳞状细胞癌

Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC

摘要

著录项

相似文献

相关主题

期刊订阅